Atika Capital Management LLC Roivant Sciences Ltd. Call Options Transaction History
Atika Capital Management LLC
- $867 Million
- Q1 2024
Call Options
1 transactions
Others Institutions Holding ROIV
# of Institutions
264Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$778 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$739 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$711 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$385 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$380 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.5B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...